GlycoMimetics Inc (NASDAQ:GLYC) shares traded 11.78% higher at $0.24 on Wall Street last session.
GLYC stock price is now -18.91% away from the 50-day moving average and -63.37% away from the 200-day moving average. The market capitalization of the company currently stands at $15.60M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On December 22, 2023, CapitalOne recently initiated its ‘Overweight’ rating on the stock quoting a target price of $12, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Invus Public Equities, L.P., 10% Owner sold 260,873 shares of the company’s stock on Aug 08 ’24. The stock was sold for $50,009 at an average price of $0.19. Upon completion of the transaction, the 10% Owner now directly owns 6,317,565 shares in the company, valued at $1.52 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 07 ’24, 10% Owner Invus Public Equities, L.P. sold 61,488 shares of the business’s stock. A total of $11,197 was realized by selling the stock at an average price of $0.18. This leaves the insider owning 6,578,438 shares of the company worth $1.58 million. A total of 11.50% of the company’s stock is owned by insiders.
During the past 12 months, GlycoMimetics Inc has had a low of $0.14 and a high of $3.53. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 3.62, and a quick ratio of 3.62. The fifty day moving average price for GLYC is $0.2972 and a two-hundred day moving average price translates $0.67255 for the stock.
The latest earnings results from GlycoMimetics Inc (NASDAQ: GLYC) was released for 2024-06-30. The net profit margin was -397354.06% and return on equity was -137.20% for GLYC.
